VIVUS Inc.

(VVUS)

By |

Profile

VIVUS Incis a biopharmaceutical company engaged in the development and commercialization of therapeutic products for large underserved markets. Its product line includes Qsymia for sleep apnea, STENDRA for erectile dysfunction.

Contact Information

Main Phone: +1 650 934-5200
Address: 351 East Evelyn Avenue
State: CA
City / Town: Mountain View
Country: USA
Postal Code: 94041

Issuer Information

Exchange: NGS
Employees: 82
NAICS: Pharmaceutical P
$ 1.40 ($ 0.01) (-0.71%)
Last Price 1.40 Change $ -0.01 Change % -0.71 Tick N/A
Bid 1.38 Bid Size 28,800.00 Ask 1.40 Ask Size 500.00
Open 1.42 High 1.46 Low 1.36 Prev Close 1.41
Last Trade Volume 650,844 52 Wk Hi 1.85 52 Wk Low 0.92
Market Cap 146.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 104,843,301.00 EPS (TTM) -0.44 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 38 60
Number of Buys 18 35
Number of Sells 20 25
Net Activity 54269 1161764
Last 10 Buys Shares
Conan Laughlin 1,000
Conan Laughlin 1,000
Conan Laughlin 1,000
Conan Laughlin 1,000
Conan Laughlin 1,000
Conan Laughlin 1,000
Conan Laughlin 1,000
Conan Laughlin 1,000
Conan Laughlin 1,000
Conan Laughlin 1,000
Last 10 Sell Shares
Santosh T Varghese 1,000
Santosh T Varghese 1,000
Santosh T Varghese 1,000
Santosh T Varghese 1,000
John L. Slebir 1,000
Santosh T Varghese 1,000
Wesley W. Day 1,000
Svai Sanford 1,000
Wesley W. Day 1,000
John L. Slebir 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 2.8 2.8 2.8 2.8
Low Target Price Estimate 2.8 2.8 1 2.8
Mean Target Price Estimate 2.8 2.8 1.9 2.8
Standard Deviation 0 0 1.27 0
Date of Most Recent Estimate 11/05/15 11/05/15 02/29/16 11/05/15
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 1 2 3 3
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
Mean Rec. 2.67 2.75 2.8 2.8